Please login to the form below

Not currently logged in
Email:
Password:

European Excellence Award for MS&L London

MS&L London has received a European Excellence Award for 'Asbestos – The Hidden Killer' on behalf of the HSE

MS&L London has received a European Excellence Award in the Health category for the campaign 'Asbestos – The Hidden Killer' on behalf of the Health & Safety Executive (HSE).

The campaign was targeted at workmen and aimed to raise awareness of the dangers of exposure to asbestos. The campaign used a football analogy to reach its target audience and was spearheaded by ex-England footballer, Ian Wright.

Steve Coldrick, HSE's asbestos programme director said: "Asbestos remains Britain's biggest workplace killer, but with the perception that it is largely a risk of the past we needed a hard-hitting PR campaign that would capture the imagination of tradesmen, particularly young ones. Using Ian Wright, a former plasterer, ticked all the boxes for us and delivered great results."

The European Excellence Awards honour outstanding achievement in the PR profession. Having been shortlisted three times, this is the second time HSE's campaign has won an award.

17th December 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aurora Healthcare Communications

We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics